On 2025-05-08, NewAmsterdam Pharma Company N.V. (NAMS) announced earnings per share of $-0.49 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.45.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.49 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.45 | $-0.49 |
| 2025-02-26 | 2024-12-31 | $-0.48 | $-0.95 |
| 2024-11-06 | 2024-09-30 | $-0.48 | $-0.18 |
| 2024-08-07 | 2024-06-30 | $-0.59 | $-0.51 |
| 2024-05-08 | 2024-03-31 | $-0.54 | $-0.62 |